Background and AimsPatients with a history of metabolic and bariatric surgery (MBS) are susceptible to developing alcohol use disorder. Outcome after transplantation for alcohol‐related liver disease (ALD) has not been studied in‐depth.MethodsWe included adult patients who underwent a liver transplantation (LT) in Belgium between 1 January 2013 and 31 December 2022 for ALD. We captured all patients with a history of MBS prior to developing ALD, and included non‐MBS patients for comparison.ResultsWe identified 39 patients who underwent MBS before developing ALD, and included 443 non‐MBS patients with an LT for ALD as controls. The median time between MBS and diagnosis of severe liver disease was 7.2 years. MBS patients were 9 years younger at the time of transplantation (p < 0.001). Pre‐LT hepatocellular carcinoma was more prevalent in the non‐MBS group (p < 0.001), while severe bacterial infections occurred more frequently in those with prior MBS. Importantly, patients with MBS had a lower survival after LT in age‐ and sex‐adjusted Cox regression analysis (HR 2.205, p = 0.023). Liver disease was listed in 70.0% versus 13.3% of patients as the main cause of death. Liver‐related mortality was linked to alcohol use relapse post‐LT, with significantly more MBS patients experiencing relapse (30.8% vs. 13.3%, p = 0.003).ConclusionFollowing MBS, excessive alcohol use can progress to end‐stage ALD and need for LT. These patients present at a younger age, with more signs of hepatic decompensation, and can be at a higher risk for post‐LT mortality, especially liver‐related death.